Drago, Filippo

Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials

Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE

Fatty Acid Research and HealthTreatment of Major Depression

Cited by 449

A cannabinoid link between mitochondria and memory

Hebert-Chatelain, E., Desprez, T., Serrat, R., Bellocchio, L., Soria-Gomez, E., Busquets-Garcia, A., Pagano Zottola, A. C., Delamarre, A., Cannich, A., Vincent, P., et al. (2016) · Nature

Cannabis and Cannabinoid ResearchMitochondrial Function and Pathology

Cited by 434

Omega-3 fatty acids and depression: scientific evidence and biological mechanisms

Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., & Caraci, F. (2014) · Oxidative Medicine and Cellular Longevity

Fatty Acid Research and HealthTryptophan and brain disorders

Cited by 351

Astroglial CB1 Receptors Determine Synaptic D-Serine Availability to Enable Recognition Memory

Robin, L. M., Oliveira da Cruz, J. F., Langlais, V. C., Martin-Fernandez, M., Metna-Laurent, M., Busquets-Garcia, A., Bellocchio, L., Soria-Gomez, E., Papouin, T., Varilh, M., et al. (2018) · Neuron

Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms

Cited by 262

Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G. M., Drago, F., & Di Marzo, V. (2009) · Neuropsychopharmacology

Cannabis and Cannabinoid ResearchIon Channels and Receptors

Cited by 207

Endocannabinoid system, stress and HPA axis

Micale, V., & Drago, F. (2018) · European Journal of Pharmacology

Cannabis and Cannabinoid ResearchStress Responses and Cortisol

Cited by 189

Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.

Bondì, M. L., Craparo, E. F., Giammona, G., & Drago, F. (2010) · Nanomedicine

Nanoparticle-Based Drug DeliveryAdvancements in Transdermal Drug Delivery

Cited by 175

Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target

Caraci, F., Spampinato, S. F., Morgese, M. G., Tascedda, F., Salluzzo, M. G., Giambirtone, M. C., Caruso, G., Munafò, A., Torrisi, S. A., Leggio, G. M., et al. (2018) · Pharmacological Research

Alzheimer's disease research and treatmentsTreatment of Major Depression

Cited by 172

Oxytocin potently enhances novelty-induced grooming behavior in the rat

Drago, F., Pedersen, C. A., Caldwell, J. D., & Prange, A. J. (1986) · Brain Research

Neuroendocrine regulation and behaviorNeuropeptides and Animal Physiology

Cited by 134

Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex

Treccani, G., Musazzi, L., Perego, C., Milanese, M., Nava, N., Bonifacino, T., Lamanna, J., Malgaroli, A., Drago, F., Racagni, G., et al. (2014) · Molecular Psychiatry

Neuroscience and Neuropharmacology ResearchStress Responses and Cortisol

Cited by 133

Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptors

Navarria, A., Wohleb, E. S., Voleti, B., Ota, K. T., Dutheil, S., Lepack, A. E., Dwyer, J. M., Fuchikami, M., Becker, A., Drago, F., et al. (2015) · Neurobiology of Disease

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 118

Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat

Amadio, M., Pascale, A., Cupri, S., Pignatello, R., Osera, C., D⿿Agata, V., D⿿Amico, A. G., Leggio, G. M., Ruozi, B., Govoni, S., et al. (2016) · Pharmacological Research

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 113

An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation

Iulita, M. F., Ower, A., Barone, C., Pentz, R., Gubert, P., Romano, C., Cantarella, R. A., Elia, F., Buono, S., Recupero, M., et al. (2016) · Alzheimer's & Dementia

Down syndrome and intellectual disability researchDementia and Cognitive Impairment Research

Cited by 99

TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway

Caraci, F., Battaglia, G., Busceti, C., Biagioni, F., Mastroiacovo, F., Bosco, P., Drago, F., Nicoletti, F., Sortino, M. A., & Copani, A. (2008) · Neurobiology of Disease

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 79

Pharmacological management of ocular hypertension: current approaches and future prospective

Bucolo, C., Salomone, S., Drago, F., Reibaldi, M., Longo, A., & Uva, M. G. (2013) · Current Opinion in Pharmacology

Glaucoma and retinal disordersDrug-Induced Ocular Toxicity

Cited by 71

Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition

Maugeri, G., Bucolo, C., Drago, F., Rossi, S., Di Rosa, M., Imbesi, R., D’Agata, V., & Giunta, S. (2021) · Frontiers in Pharmacology

Retinal Diseases and TreatmentsAdvanced Glycation End Products research

Cited by 47

Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice

Maurel, O. M., Torrisi, S. A., Barbagallo, C., Purrello, M., Salomone, S., Drago, F., Ragusa, M., & Leggio, G. M. (2021) · International Journal of Molecular Sciences

Posttraumatic Stress Disorder ResearchMicroRNA in disease regulation

Cited by 44

The lifetime prevalence and impact of generalized anxiety disorders in an epidemiologic Italian National Survey carried out by clinicians by means of semi-structured interviews

Preti, A., Demontis, R., Cossu, G., Kalcev, G., Cabras, F., Moro, M. F., Romano, F., Balestrieri, M., Caraci, F., Dell’Osso, L., et al. (2021) · BMC Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 31

Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors improve cognitive function in partial responders depressed patients: Results from a prospective observational cohort study

Castellano, S., Ventimiglia, A., Salomone, S., Ventimiglia, A., Vivo, S., Signorelli, M., Bellelli, E., Santagati, M., Cantarella, R., Fazio, E., et al. (2016) · CNS & Neurological Disorders - Drug Targets

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 31

The Prevalence of Specific Phobia by Age in an Italian Nationwide Survey: How Much Does it Affect the Quality of Life?

Sancassiani, F., Romano, F., Balestrieri, M., Caraci, F., Di Sciascio, G., Drago, F., Hardoy, M. C., Moro, M. F., Roncone, R., Piras, M., et al. (2019) · Clinical Practice & Epidemiology in Mental Health

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesMental Health Treatment and Access

Cited by 24

Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

Caraci, F., Iulita, M. F., Pentz, R., Flores Aguilar, L., Orciani, C., Barone, C., Romano, C., Drago, F., & Cuello, A. C. (2017) · European Journal of Pharmacology

Alzheimer's disease research and treatmentsDown syndrome and intellectual disability research

Cited by 18

Reversible inhibition of vasoconstriction by thiazolidinediones related to PI3K/Akt inhibition in vascular smooth muscle cells.

Sinagra, T., Tamburella, A., Urso, V., Siarkos, I., Drago, F., Bucolo, C., & Salomone, S. (2013) · Biochemical Pharmacology

Peroxisome Proliferator-Activated ReceptorsNitric Oxide and Endothelin Effects

Cited by 18